Utility of 18F-FDG PET/CT for the prediction of pathologic complete response in axilla to neoadjuvant chemotherapy in breast cancer

被引:0
|
作者
Michel, Eloise
Beltjens, Francoise
Cochet, Alexandre
Alberini, Jean Louis
Coutant, Charles
Jankowski, Clementine
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P5-01-11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5-01-11
引用
收藏
页数:2
相关论文
共 50 条
  • [21] MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
    Weber, Joseph J.
    Jochelson, Maxine S.
    Eaton, Anne
    Zabor, Emily C.
    Barrio, Andrea V.
    Gemignani, Mary L.
    Pilewskie, Melissa
    Van Zee, Kimberly J.
    Morrow, Monica
    El-Tamer, Mahmoud
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (06) : 740 - 746
  • [22] Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Umutlu, Lale
    Kirchner, Julian
    Bruckmann, Nils-Martin
    Morawitz, Janna
    Antoch, Gerald
    Ting, Saskia
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Haeberle, Lena
    Ruckhaeberle, Eugen
    Catalano, Onofrio Antonio
    Chodyla, Michal
    Grueneisen, Johannes
    Quick, Harald H.
    Fendler, Wolfgang P.
    Rischpler, Christoph
    Herrmann, Ken
    Gibbs, Peter
    Pinker, Katja
    CANCERS, 2022, 14 (07)
  • [23] Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
    In Hee Lee
    Soo Jung Lee
    Jeeyeon Lee
    Jin Hyang Jung
    Ho Yong Park
    Shin Young Jeong
    Sang-woo Lee
    Yee Soo Chae
    BMC Cancer, 20
  • [24] Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
    Lee, In Hee
    Lee, Soo Jung
    Lee, Jeeyeon
    Jung, Jin Hyang
    Park, Ho Yong
    Jeong, Shin Young
    Lee, Sang-woo
    Chae, Yee Soo
    BMC CANCER, 2020, 20 (01)
  • [25] Prediction of the histopathological response to neoadjuvant chemotherapy by F-18-FDG PET/CT in patients with breast cancer
    Taki, Junichi
    Inokuchi, Masafumi
    Wakabayashi, Hiroshi
    Inaki, Anri
    Nakamura, Ayane
    Mochizuki, Takafumi
    Kinuya, Seigo
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [26] Correlation of Breast Cancer Subgroups and Axillary Metastases with 18F-FDG PET/CT and the Contribution of 18F-FDG PET/CT in the Management of the Axilla
    Ozer, Nazmi
    Sahin, Abdullah
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (02): : 150 - 155
  • [27] Contribution of tumour blood-flow for prediction of response to neoadjuvant chemotherapy in breast cancer using 18F-FDG PET/CT
    Payan, N.
    Presles, B.
    Vrigneaud, J. M.
    Cochet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S139 - S139
  • [28] Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT
    Evangelista, Laura
    Cervino, Anna R.
    Michieletto, Silvia
    Saibene, Tania
    Orvieto, Enrico
    Bozza, Fernando
    Ghiotto, Cristina
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (02): : 205 - 215
  • [29] 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Cheng, Xu
    Li, Yongjun
    Liu, Biao
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [30] 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
    Cheng, Xu
    Li, Yongjun
    Liu, Biao
    Xu, Zhaoqiang
    Bao, Lihua
    Wang, Jie
    ACTA RADIOLOGICA, 2012, 53 (06) : 615 - 627